Any current/future capex/capital investment/strategic investment?

Black Rose Industries is planning a polyacrylamide solid plant requiring an investment between ₹60 to ₹100 crore, depending on the technology chosen (domestic or imported). The company is in advanced discussions for a specialty chemicals project at the Jhagadia site in collaboration with a Japanese principal. Talks are underway for two toll manufacturing projects related to acrylamide chemistry with companies from Europe and the US. The company is also seeking to acquire about 20 acres of new land for future projects and expansion requirements. Fund-raising for these investments will be consid

Future growth expectations in sales/revenue/volumes?

Acrylamide solid export volumes expected to increase this quarter due to new customer acquisition and better product acceptance despite global market disruptions (Page 17). Polyacrylamide liquid sales affected by subdued demand in Morbi tile industry but new R&D efforts on improved binders and dispersants aim to boost revenue and product mix (Page 5). NMA (N-Methyl Acetoacetamide) commercial sales started with a large customer, expected to raise revenue and profit substantially (Page 5). Distribution business anticipates substantial volume and revenue growth supported by stable domestic demand

Future growth expectations in earnings/operating earnings/profits/EPS?

Manufacturing revenue at full capacity for current four products is estimated between ₹300-400 crores, though market prices are variable (Page 14). Company aims to maximize sales and revenue rather than focus solely on capacity utilization (Page 14). Export volumes for acrylamide solid are expected to increase in the current quarter by reaching new customers, compensating for some global market disruptions (Page 17). Distribution volumes and revenues are anticipated to increase substantially due to stable domestic demand, improved supplies, and renewed export demand, particularly from the US (

Current/ Expected Orderbook/ Pending Orders?

The transcript does not provide explicit details on the current or expected order book and pending orders for Black Rose Industries Limited. There are concerns raised by participant Dhaval Shah about the slow execution and prolonged negotiations (e.g., toll management contracts ongoing for 6-9 months). No specific figures or definitive timelines are shared regarding order backlog or pending orders during the Q3 FY24 webinar. The company emphasizes focus on maximizing sales and expanding exports, especially for acrylamide solid, by reaching newer customers. Manufacturing volumes are described a

Black Rose Industries LtdQ3 FY24Chemicals & Petrochemicals

Black Rose Industries Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹110P/E: 20.6Market Cap: ₹591 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Acrylamide solid export volumes expected to increase this quarter due to new customer acquisition and better product acceptance despite global market disruptions (Page 17).
Polyacrylamide liquid sales affected by subdued demand in Morbi tile industry but new R&D efforts on improved binders and dispersants aim to boost revenue and product mix (Page 5).
NMA (N-Methyl Acetoacetamide) commercial sales started with a large customer, expected to raise revenue and profit substantially (Page 5).
Distribution business anticipates substantial volume and revenue growth supported by stable domestic demand, improved supply from principals, and expected export volume pick-up after US demand revival (Page 4).
Manufacturing volumes largely flat quarter-to-quarter, but 9 months show slight growth with expectation to surpass previous fiscal year volumes (Page 15).
At full capacity and current market conditions, manufacturing revenue potential estimated between ₹300 to ₹400 crores (Page 14).
Overall focus remains on maximizing sales, revenue, and profitability aligned with competitive pricing and cost efficiencies (Pages 14-17).

Margin guidance

Category 3

Manufacturing revenue at full capacity for current four products is estimated between ₹300-400 crores, though market prices are variable (Page 14).
Company aims to maximize sales and revenue rather than focus solely on capacity utilization (Page 14).
Export volumes for acrylamide solid are expected to increase in the current quarter by reaching new customers, compensating for some global market disruptions (Page 17).
Distribution volumes and revenues are anticipated to increase substantially due to stable domestic demand, improved supplies, and renewed export demand, particularly from the US (Page 4).
EBITDA margins have improved for the fifth consecutive quarter, indicating ongoing profitability improvement (Page 3).
The focus remains on prudent raw material management and R&D to enhance product mix and margins (Pages 4,5).
Overall, the company expects to beat the previous financial year's manufacturing volumes by year-end, projecting growth in earnings and profitability (Page 15).

See what Black Rose Industries Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

- The company has not indicated any immediate plans to raise funds currently. - Mentioned that once technology and processes for new projects are finalized, they will consider fundraising options at the appropriate time. - Specifically, for the polyacrylamide solid plant, an investment of ₹60 to ₹100 crores is anticipated depending on the technology chosen. - The mode of raising this capital (debt/equity) will be decided when implementation starts. - Management emphasized no current need to raise funds or dilute equity. - Any future fundraising will be aligned with project requirements and finalized plans. In summary, no current fundraising is underway, but future fundraising may occur based on technology finalization and project commencement.

Order book

The transcript does not provide explicit details on the current or expected order book and pending orders for Black Rose Industries Limited.
There are concerns raised by participant Dhaval Shah about the slow execution and prolonged negotiations (e.g., toll management contracts ongoing for 6-9 months).
No specific figures or definitive timelines are shared regarding order backlog or pending orders during the Q3 FY24 webinar.
The company emphasizes focus on maximizing sales and expanding exports, especially for acrylamide solid, by reaching newer customers.
Manufacturing volumes are described as flattish to slightly higher compared to the previous year, indicating stable order flow but no quantified order book details.
Management refrains from sharing sensitive capacity or order specifics to avoid disclosing information to competitors.

See what Black Rose Industries Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Black Rose Industries is planning a polyacrylamide solid plant requiring an investment between ₹60 to ₹100 crore, depending on the technology chosen (domestic or imported).
The company is in advanced discussions for a specialty chemicals project at the Jhagadia site in collaboration with a Japanese principal.
Talks are underway for two toll manufacturing projects related to acrylamide chemistry with companies from Europe and the US.
The company is also seeking to acquire about 20 acres of new land for future projects and expansion requirements.
Fund-raising for these investments will be considered at the appropriate time after finalizing the technology and project details.
Current capital expenditure on existing capacity setups (like NMA and acrylamide solid) has been very low, benefiting from low CapEx structures.

Track Black Rose Industries Ltd — get its next earnings analysis in your feed

How does Black Rose Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisBlack Rose Industries Ltd

Rev 3Mar 3

See where Black Rose Industries Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Black Rose Industries Ltd rank in Chemicals & Petrochemicals?

Compare Black Rose Industries Ltd against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Black Rose Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Black Rose Industries Ltd Q3 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Black Rose Industries Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Black Rose Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season